Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
FB-418 by 1St Bio Therapeutics for Parkinson's Disease: Likelihood of Approval
FB-418 is under clinical development by 1St Bio Therapeutics and currently in Phase I for Parkinson's Disease. According to GlobalData,...
Data Insights
FB-418 by 1St Bio Therapeutics for Amyotrophic Lateral Sclerosis: Likelihood of Approval
FB-418 is under clinical development by 1St Bio Therapeutics and currently in Phase I for Amyotrophic Lateral Sclerosis. According to...